Beyond the Lungs-Emerging Challenges in Adult Cystic Fibrosis Care

被引：5
作者：
Mulrennan, Siobhain [1 ]
Sapru, Karuna [2 ]
Tewkesbury, Daniel [2 ]
Jones, Andrew M. [2 ,3 ]
机构：
[1] Sir Charles Gairdner Hosp, Perth, Australia
[2] Wythenshawe Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester, England
[3] Wythenshawe Hosp, Manchester Adult Cyst Fibrosis Ctr, Southmoor Rd, Manchester M23 9LT, England
来源：
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 44卷 / 02期
关键词：
cystic fibrosis; CFTR modulators; aging; malignancy; cardiovascular disease; bone health; RISK-FACTORS; VERTEBRAL FRACTURES; LIVER-DISEASE; DEPRESSION; PREGNANCY; HEALTH; WOMEN; PREVALENCE; CFTR; ASSOCIATION;
D O I：
10.1055/s-0042-1758734
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Cystic fibrosis (CF) is a multisystem disease. This article provides an up-to-date review of many of the nonrespiratory complications of CF, including mental health issues, nutritional and gastrointestinal problems, fertility issues, diabetes mellitus, bone health and musculoskeletal problems, liver disease, renal problems, and risk of malignancy. It highlights the recent impact of new therapies, including CF transmembrane conductance regulator modulators, on the nonrespiratory complications of CF and provides insights into the potential challenges faced by an aging population of adults with CF and their caregivers, including the potential future risk for cardiovascular disease.
引用
收藏
页码：307 / 313
页数：7
相关论文
共 50 条
  • [31] Perioperative Management of the Adult with Cystic Fibrosis
    Huffmyer, Julie L.
    Littlewood, Keith E.
    Nemergut, Edward C.
    ANESTHESIA AND ANALGESIA, 2009, 109 (06) : 1949 - 1961
  • [32] Emerging microRNA Therapeutic Approaches for Cystic Fibrosis
    Bardin, Pauline
    Sonneville, Florence
    Corvol, Harriet
    Tabary, Olivier
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [33] Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosis
    Mudgil, Umang
    Khullar, Lavanya
    Chadha, Jatin
    Harjai, Kusum
    MICROBIAL PATHOGENESIS, 2024, 193
  • [34] Challenges in the use of highly effective modulator treatment for cystic fibrosis
    Ramos, Kathleen J.
    Pilewski, Joseph M.
    Taylor-Cousar, Jennifer L.
    JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (03) : 381 - 387
  • [35] Cystic Fibrosis Foundation and European Cystic Fibrosis Society, Survey of cystic fibrosis mental health care delivery
    Abbott, J.
    Elborn, J. S.
    Georgiopoulos, A. M.
    Goldbeck, L.
    Marshall, B. C.
    Sabadosa, K. A.
    Smith, B. A.
    Quittner, A. L.
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (04) : 533 - 539
  • [36] Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs
    Kovacic, Barbara
    Sehl, Carolin
    Wilker, Barbara
    Kamler, Markus
    Gulbins, Erich
    Becker, Katrin Anne
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 41 (03) : 1208 - 1218
  • [37] Emerging Treatments in Cystic Fibrosis
    Andrew M. Jones
    Jennifer M. Helm
    Drugs, 2009, 69 : 1903 - 1910
  • [38] Cystic fibrosis care in transition from adolescence to adult age
    Fischer, R.
    Naehrig, S.
    Kappler, M.
    Griese, M.
    INTERNIST, 2009, 50 (10): : 1213 - +
  • [39] Emerging drugs for cystic fibrosis
    Amin, Reshma
    Ratjen, Felix
    EXPERT OPINION ON EMERGING DRUGS, 2014, 19 (01) : 143 - 155
  • [40] Transition of adolescents with cystic fibrosis from paediatric to adult care
    Towns, Susan Joy
    Bell, Scott Cameron
    CLINICAL RESPIRATORY JOURNAL, 2011, 5 (02) : 64 - 75
12345